Total decompression after diagnostic colonoscopy decreases abdominal pain: A randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000979

Enrollment

294

Registered

2014-01-10

Start date

2013-08-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Study Population We prospectively evaluated consecutive asymptomatic patients who were receiving elective colonoscopy for screening, surveillance, or medical check-up at Cheju Hall

(2) surgically altered colonic anatomy (such as hemicolectomy or segmental colorectal resection)

(3) American Society of Anesthesiology risk Class 3 or higher

(4) allergy to propofol, soybeans, or eggs

(5) contraindication to hyoscine butylbromide

(6) failure to comply with the recommended bowel preparation regimen

(7) current analgesics including non-steroidal anti-inflammatory drugs use during the preceding week (acetylsalicylic acid 100 mg daily or less acceptable)

(8) no response to our research with telephone

and (9) declining to provide informed consent. Finally, for the patients' safety and comfort, the patients with difficult insertion were excluded who underwent colonoscopy over 10 minutes for cecal in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Between study periods, we prospectively evaluate consecutive asymptomatic patients who were receiving elective colonoscopy for screening, surveillance, or medical check-up at the Jeju Halla General Hospital.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: (1) age younger than 18 years; (2) surgically altered colonic anatomy (such as hemicolectomy or segmental colorectal resection); (3) American Society of Anesthesiology risk Class 3 or higher; (4) allergy to propofol, soybeans, or eggs; (5) contraindication to hyoscine butylbromide; (6) failure to comply with the recommended bowel preparation regimen; (7) current analgesics including non-steroidal anti-inflammatory drugs use during the preceding week (acetylsalicylic acid 100 mg daily or less acceptable); (8) no response to our research with telephone; and (9) declining to provide informed consent. Finally, for the patients’ safety and comfort, the patients with difficult insertion were excluded who underwent colonoscopy over 10 minutes for cecal intubation.

Design outcomes

Primary

Measure	Time frame
The incidence of abdominal pain after colonoscopy	—

Secondary

Measure	Time frame
The severity of abdominal pain after colonoscopy	—

Countries

Korea, Republic of

Contacts

Public ContactSe Woo Park

Cheju Halla General Hospital

Outcome results